Evidence map›Paper›PMID 28315782›Full record

ArticleNeurobiology of disease2017

Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice.

Oscar Solís, Jose-Rubén García-Montes, Patricia Garcia-Sanz, Antonio S Herranz, Maria-José Asensio, Gina Kang, Noboru Hiroi, Rosario Moratalla

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease.medRxiv : the preprint server for health sciences · 2023
    Article
  4. The pathogenesis of blepharospasm.Frontiers in neurology · 2023
    Review
  5. Article
  6. Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.Movement disorders : official journal of the Movement Disorder Society · 2020
    Article
  7. Effort-related decision making in humanized COMT mice: Effects of ValPharmacology, biochemistry, and behavior · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
  13. Levodopa treatment and dendritic spine pathology.Movement disorders : official journal of the Movement Disorder Society · 2018
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Oscar SolísInstituto Cajal, CSIC, Madrid 28002, Spain; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.
Jose-Rubén García-MontesInstituto Cajal, CSIC, Madrid 28002, Spain; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.
Patricia Garcia-SanzInstituto Cajal, CSIC, Madrid 28002, Spain; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain.
Antonio S HerranzServicio de Neurobiología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid 28034, Spain.
Maria-José AsensioServicio de Neurobiología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid 28034, Spain.
Gina KangDepartment of Psychiatry and Behavioral Sciences, Dominick P. Purpura Department of Neuroscience, and Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Noboru HiroiDepartment of Psychiatry and Behavioral Sciences, Dominick P. Purpura Department of Neuroscience, and Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Rosario MoratallaInstituto Cajal, CSIC, Madrid 28002, Spain; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: moratalla@cajal.csic.es.
Instituto Cajal · ESAlbert Einstein College of Medicine · USInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

Support for the Rose F. Kennedy IDDRCU54HD090260 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WALKLEY, STEVEN UPSHAW · 2016 to 2020
$6.0M
Postnatal mechanisms of cognitive development in miceR01MH099660 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Noboru Hiroi · 2013 to 2026
$5.9M
NICHD NIH HHS U54 HD090260NIMH NIH HHS R01 MH099660
6 · The paper itself

Abstract

Catechol-O-methyltransferase (COMT) degrades dopamine and its precursor l-DOPA and plays a critical role in regulating synaptic dopamine actions. We investigated the effects of heightened levels of COMT on dopamine-regulated motor behaviors and molecular alterations in a mouse model of dyskinesia. Transgenic mice overexpressing human COMT (TG) and their wildtype (WT) littermates received unilateral 6-OHDA lesions in the dorsal striatum and were treated chronically with l-DOPA for two weeks. l-DOPA-induced dyskinesia was exacerbated in TG mice without altering l-DOPA motor efficacy as determined by contralateral rotations or motor coordination. Inductions of FosB and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG mice compared with their WT littermates. The TG mice had lower basal levels of dopamine in the striatum. In mice with lesions, l-DOPA induces a greater increase in the dopamine metabolite 3-methoxytyramine in the lesioned striatum of dyskinetic TG mice than in WT mice. The levels of serotonin and its metabolite were similar in TG and WT mice. Our results demonstrate that human COMT overexpression confers a heightened susceptibility to l-DOPA-induced dyskinesia and alters molecular and neurochemical responses in the lesioned striatum of mice.

Indexed as

AnimalsAntiparkinson AgentsArmadillo Domain ProteinsCatechol O-MethyltransferaseCell Adhesion MoleculesCorpus StriatumDisease Models, AnimalDisease SusceptibilityDopamineDyskinesia, Drug-InducedHumansLevodopaMice, Inbred C57BLMice, TransgenicMotor ActivityOxidopamineAntiparkinson AgentsArmadillo Domain ProteinsARVCF protein, humanCatechol O-MethyltransferaseCell Adhesion MoleculesCOMT protein, humanDopamineLevodopaOxidopaminePhosphoproteinsProto-Oncogene Proteins c-fosSerotoninThioredoxin Reductase 2TXNRD2 protein, human22q11.2Abnormal involuntary movementsARVCFCOMTDopaminel-DOPALIDStriatumTXNRD2

Identifiers

PMID28315782
PMCPMC5481205
OpenAlexW2595517396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.